Inspire Medical Systems, Inc.

NYSE:INSP Stok Raporu

Piyasa değeri: US$6.4b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Inspire Medical Systems Yönetim

Yönetim kriter kontrolleri 4/4

Inspire Medical Systems' CEO'su Tim Herbert, Nov2007 tarihinde atandı, in görev süresi 16.92 yıldır. in toplam yıllık tazminatı $ 7.49M olup, şirket hissesi ve opsiyonları dahil olmak üzere 9.2% maaş ve 90.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.99% ine doğrudan sahiptir ve bu hisseler $ 62.32M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.3 yıl ve 5.3 yıldır.

Anahtar bilgiler

Tim Herbert

İcra Kurulu Başkanı

US$7.5m

Toplam tazminat

CEO maaş yüzdesi9.2%
CEO görev süresi16.9yrs
CEO sahipliği1.0%
Yönetim ortalama görev süresi4.3yrs
Yönetim Kurulu ortalama görev süresi5.3yrs

Son yönetim güncellemeleri

Recent updates

Is Now The Time To Look At Buying Inspire Medical Systems, Inc. (NYSE:INSP)?

Oct 03
Is Now The Time To Look At Buying Inspire Medical Systems, Inc. (NYSE:INSP)?

After Leaping 39% Inspire Medical Systems, Inc. (NYSE:INSP) Shares Are Not Flying Under The Radar

Aug 08
After Leaping 39% Inspire Medical Systems, Inc. (NYSE:INSP) Shares Are Not Flying Under The Radar

Is Inspire Medical Systems, Inc. (NYSE:INSP) Trading At A 39% Discount?

Jul 17
Is Inspire Medical Systems, Inc. (NYSE:INSP) Trading At A 39% Discount?

At US$162, Is It Time To Put Inspire Medical Systems, Inc. (NYSE:INSP) On Your Watch List?

Jun 22
At US$162, Is It Time To Put Inspire Medical Systems, Inc. (NYSE:INSP) On Your Watch List?

Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors

May 09
Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors

Inspire Medical Systems: A Potential Example Of Market Mispricing

Apr 05

Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate

Mar 27
Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate

Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?

Mar 06
Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?

Inspire Medical: A Good Night Sleep

Feb 08

Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors

Dec 26
Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors

Inspire Medical Systems: Time To Wake Up

Nov 17

An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued

Nov 13
An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued

Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth

Oct 25

When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?

Sep 05
When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?

Inspire Medical Systems: Excellent Execution And Reset Valuation

Aug 17

Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?

Aug 10
Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?

Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment

Jul 19

Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing

Jul 16
Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing

Inspire Medical Systems: Valuation, Sentiment, Fundamental Factors Call For Re-Rating

Jun 15

Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching

May 06
Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching

Inspire Medical stock rises after guiding revenue above estimates

Jan 09

Inspire Medical nears eight-month high as KeyBanc issues bullish call

Dec 13

Inspire Medical Systems: Sleep Apnea Equipment - Today's Best Stock Buy

Oct 26

CEO Tazminat Analizi

Tim Herbert'un ücretlendirmesi Inspire Medical Systems'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

US$6m

Mar 31 2024n/an/a

-US$16m

Dec 31 2023US$7mUS$690k

-US$21m

Sep 30 2023n/an/a

-US$33m

Jun 30 2023n/an/a

-US$41m

Mar 31 2023n/an/a

-US$44m

Dec 31 2022US$6mUS$645k

-US$45m

Sep 30 2022n/an/a

-US$50m

Jun 30 2022n/an/a

-US$44m

Mar 31 2022n/an/a

-US$43m

Dec 31 2021US$1mUS$620k

-US$42m

Sep 30 2021n/an/a

-US$47m

Jun 30 2021n/an/a

-US$47m

Mar 31 2021n/an/a

-US$57m

Dec 31 2020US$5mUS$506k

-US$57m

Sep 30 2020n/an/a

-US$59m

Jun 30 2020n/an/a

-US$57m

Mar 31 2020n/an/a

-US$41m

Dec 31 2019US$3mUS$440k

-US$33m

Sep 30 2019n/an/a

-US$29m

Jun 30 2019n/an/a

-US$25m

Mar 31 2019n/an/a

-US$24m

Dec 31 2018US$3mUS$418k

-US$22m

Sep 30 2018n/an/a

-US$21m

Jun 30 2018n/an/a

-US$21m

Mar 31 2018n/an/a

-US$20m

Dec 31 2017US$600kUS$380k

-US$18m

Tazminat ve Piyasa: Tim 'ın toplam tazminatı ($USD 7.49M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 8.11M ).

Tazminat ve Kazançlar: Tim 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Tim Herbert (61 yo)

16.9yrs

Görev süresi

US$7,490,775

Tazminat

Mr. Timothy P. Herbert, also known as Tim, has been Chief Executive Officer, President and Director of Inspire Medical Systems, Inc. since November 2007 and has been its Chairman since May 2, 2024. He is t...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Timothy Herbert
Founder16.9yrsUS$7.49m0.99%
$ 63.5m
Richard Buchholz
Chief Financial Officer10.4yrsUS$2.30m0.10%
$ 6.6m
Randall Ban
Chief Commercial Officer5.8yrsUS$2.26m0.0023%
$ 149.3k
Charisse Sparks
Chief Medical Officer1.3yrsUS$211.35k0.0031%
$ 200.6k
Carlton Weatherby
Chief Strategy Officer1.3yrsUS$2.10m0%
$ 0
John Rondoni
Chief Technology Officer2.4yrsUS$2.10m0.029%
$ 1.9m
Ezgi Yagci
Vice President of Investor Relationsno dataVeri yokVeri yok
Bryan Phillips
Senior VP3.8yrsUS$2.69m0.0044%
$ 281.4k
Melissa Mann
Chief People Officerless than a yearVeri yokVeri yok
Ivan Lubogo
Senior Vice President of U.S. Sales4.8yrsVeri yokVeri yok
Andreas Henke
Executive VP & MD of Europe4.8yrsVeri yokVeri yok
Megan Rowekamp
Director of Financial Reportingno dataVeri yokVeri yok

4.3yrs

Ortalama Görev Süresi

56yo

Ortalama Yaş

Deneyimli Yönetim: INSP 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.3 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Timothy Herbert
Founder16.9yrsUS$7.49m0.99%
$ 63.5m
Casey Tansey
Independent Director16.8yrsUS$235.88k0.069%
$ 4.4m
Dana Mead
Independent Director16.3yrsUS$238.38k0.069%
$ 4.4m
Shawn McCormick
Independent Director7.8yrsUS$248.38k0.085%
$ 5.5m
Shelley Broader
Independent Director4yrsUS$243.38k0.0057%
$ 366.6k
Gary Ellis
Lead Independent Director5.3yrsUS$243.38k0.012%
$ 743.5k
Georgia Garinois-Melenikiotou
Independent Director4.3yrsUS$238.38k0.0047%
$ 304.5k
Myriam J. McAdams
Independent Directorless than a yearUS$271.56k0%
$ 0
Cynthia Burks
Independent Director2.3yrsUS$235.88k0.0022%
$ 143.6k

5.3yrs

Ortalama Görev Süresi

65yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: INSP 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.3 yıldır).